Tarek Benzouak

McGill University Health Centre

Papers

1

Total Citations

13

H-Index

1

About

Tarek Benzouak is a rising figure in urological surgery, whose work centers on advancing minimally invasive treatments for benign prostatic hyperplasia (BPH). His major contributions lie in comparative effectiveness research, most notably through a landmark 2024 systematic review and meta-analysis that rigorously evaluated holmium laser enucleation of the prostate (HoLEP) against robotic-assisted simple prostatectomy (RASP). This study, already garnering 13 citations shortly after publication, provides critical evidence for surgeons selecting between these two modern techniques, emphasizing outcomes such as efficacy, safety, and recovery efficiency. By synthesizing data to clarify the trade-offs between laser and robotic approaches, Benzouak’s work directly informs clinical decision-making in an era of increasing BPH prevalence. His research demonstrates a commitment to evidence-based urology and surgical optimization, offering practical guidance for improving patient outcomes. As a researcher, Benzouak is establishing himself as a key voice in the evolution of prostate surgery, bridging technological innovation with rigorous comparative analysis.

Research Focus

Key Achievements

1
H-Index
1
Papers
13
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
Comparative Analysis of Holmium Laser Enucleation of the Prostate (HoLEP) and Robotic-Assisted Simple Prostatectomy (RASP) in BPH Management: A Systematic Review and Meta-Analysis
13 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: McGill University Health Centre

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago